UNC Lineberger Comprehensive Cancer Center: all 424 studies
Page 4 of 5. Open to participants first (96), then studies with results posted, then the rest; newest registration first within each.
- Promoting Physical Activity in Young Adult Cancer Survivors Using mHealth and Adaptive Tailored Feedback StrategiesCompletedNCT03569605Not applicable
- 18-FLT PET/MR Imaging to Predict Graft Failure and GVHD in Bone Marrow Transplant PatientsTerminatedNCT03546556Early Phase 1
- Pilot Evaluation of a Microfluidic Assay to Detect Minimal Residual Disease and Predict Relapse in AML PatientsCompletedNCT03488862
- Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the OropharynxCompletedNCT03418792Not applicable
- mHealth Physical Activity Intervention for Survivors of Adolescent and Young Adult CancersCompletedNCT03386383Not applicable
- Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBCTerminatedNCT03361800Early Phase 1
- Selective Image Guided Resection of Pathologically Documented Axillary Lymph Node MetastasesCompletedNCT03281720Not applicable
- Feasibility of an 8-week Tai Chi Chuan Intervention for Breast Cancer SurvivorsCompletedNCT03196037Not applicable
- Mailed Reminders Plus Fecal Immunochemical TestingCompletedNCT03176082Not applicable
- Plasma Circulating Tumor DNA Analyses in ER+ Metastatic Breast CancerWithdrawnNCT03161834
- Circulating Tumor Cells in Solid TumorsCompletedNCT03161821
- HIV and Other Risk Factors for Esophageal Squamous Cell Carcinoma in MalawiCompletedNCT03160209
- Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in MalawiCompletedNCT03160183
- Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer PatientsCompletedNCT03156244
- Pre-Post Study for Supporting Appropriate Implementation of Lung Cancer ScreeningCompletedNCT03077230Not applicable
- Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALLActive, not recruitingNCT03016377Phase 1
- Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data GenerationCompletedNCT02844400
- Clinical Cohort of Lymphoma Patients in MalawiActive, not recruitingNCT02835911
- A Patient Portal Tool, E-assist, for Supporting CRC ScreeningCompletedNCT02798224Not applicable
- Assessing Physical Fitness in Cancer Patients With Cardiopulmonary Exercise Testing and Wearable Data GenerationCompletedNCT02786628
- Culture of Circulating Tumor Cells Isolated From Cancer Patients With Metastatic DiseaseCompletedNCT02781025
- A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the EndometriumCompletedNCT02767362Early Phase 1
- A Phase I Study of Alisertib + R-EPOCH for Treatment of Myc-Positive Aggressive B-cell LymphomasTerminatedNCT02700022Phase 1
- Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHLActive, not recruitingNCT02690545Phase 1/2
- Physical Activity to Maintain Quality of Life and Physical Function in Women With Metastatic Breast Cancer: a Pilot StudyCompletedNCT02682836Not applicable
- Prospective Evaluation of Patient Reported Xerostomia After Whole Brain RadiationCompletedNCT02682199
- Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell LymphomaCompletedNCT02660710Phase 2
- Effect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Test 3CompletedNCT02651883Not applicable
- Dose-escalating AZD1775 + Concurrent Radiation + Cisplatin for Intermediate/High Risk HNSCCCompletedNCT02585973Phase 1
- Evaluation of Cardiorespiratory Performance After Interval Exercise Training Prior to Hematopoietic Cell TransplantationCompletedNCT02577939Not applicable
- The Ability of Electronic Patient Symptom Reporting to Reduce Symptom Burden During Hospitalization for ChemotherapyCompletedNCT02574897Not applicable
- Fitness in Allogeneic Stem Cell TransplantationCompletedNCT02564458Not applicable
- Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation TherapyCompletedNCT02449837
- Impact of Physical Activity on Biomarker of Aging and Body Composition Among Breast Cancer Survivors Age 65 and OlderCompletedNCT02328313Not applicable
- FLT PET/MR for Evaluation of Pseudoprogression in Patients With Brain LesionsWithdrawnNCT02328300
- The CARE Program: CAncer REhabilitation Pilot Study for Older AdultsCompletedNCT02306252Not applicable
- Radiation Induced Cardiopulmonary Injury in HumansTerminatedNCT02259452
- Exercise and Quality of Life in Leukemia PatientsCompletedNCT02246907Not applicable
- The Effect of Walking on Fatigue After Chemotherapy in Patients 65 and OlderCompletedNCT02191982Not applicable
- Physical Activity Intervention for Older Patients During Chemotherapy for Colorectal CancerCompletedNCT02191969Not applicable
- The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast CancerCompletedNCT02167932
- Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate CancerTerminatedNCT02139774
- Exercise Intervention for Pts With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or EnzalutamideWithdrawnNCT02130947Not applicable
- Improving Survivorship Care Through Enhanced Communication and Coordination: Pilot StudyCompletedNCT02111616Not applicable
- Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)TerminatedNCT02045186Not applicable
- Retinal Oxygen Function After Radiation TherapyCompletedNCT02043470
- The Use of Smart Scales for Weight Gain Prevention in African American Breast Cancer SurvivorsCompletedNCT02030353Not applicable
- Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate CancerCompletedNCT02008058
- Radiation Adherence/Toxicity in Patients With Non-Ovarian Gynecological CancersCompletedNCT02003430
- Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone TherapyCompletedNCT02003417
- Pilot Study: Utilizing Manometry to Assess Radiation-Induced Changes in Esophageal FunctionTerminatedNCT01992068
- Single Subject Neratinib in Bladder Cancer (NRR)No longer availableNCT01956253
- Preoperative Window Study of Metformin for the Treatment of Endometrial CancerCompletedNCT01911247Early Phase 1
- Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + LapatinibCompletedNCT01875666Early Phase 1
- Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid TumorsCompletedNCT01859858Phase 1
- Assessment of Ability of Breath Hold for Left-sided Breast Cancer Radiation Therapy to Reduce Side Effects to HeartCompletedNCT01849614
- PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1)CompletedNCT01800032
- Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During ChemotherapyCompletedNCT01789983
- Study of Outcomes After Surgery/Treatment to Treat Bladder CancerCompletedNCT01776138
- Comparison of Stationary Breast Tomosynthesis and 2-D Digital Mammography in Patients With Known Breast LesionsCompletedNCT01773850
- Hybrid PET/MR in the Therapy of Cervical CancerCompletedNCT01759355
- Predicting Tolerance to Radiation Therapy in Older Adults With CancerCompletedNCT01752751
- Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal CancerCompletedNCT01751529Early Phase 1
- PET/MRI as a Predictor of Response to Pre-op Chemoradiation in Resectable Rectal Cancer: a Pilot StudyCompletedNCT01751516
- Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With CancerCompletedNCT01725048Early Phase 1
- Finding Predictors of Side Effects to Chemoradiation Treatment in Elderly Patients With Head and Neck CancerCompletedNCT01688323
- Metformin for the Treatment of Endometrial HyperplasiaCompletedNCT01685762Early Phase 1
- Imaging Correlates of Renal Cell Carcinoma Biological FeaturesCompletedNCT01665703Not applicable
- Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder CancerCompletedNCT01655745Not applicable
- Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRIWithdrawnNCT01605344Phase 1
- Lenalidomide as Consolidation and Maintenance in Adults >/= 60 Years of Age With AML Following Standard InductionCompletedNCT01578954Phase 1
- BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic CancerCompletedNCT01571024Phase 1
- Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple MyelomaWithdrawnNCT01492881Phase 2
- Patient Preferences for Breast Reconstruction After MastectomyCompletedNCT01488357
- Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212CompletedNCT01467310Early Phase 1
- Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) SubjectsCompletedNCT01323062Phase 1
- Administration of T Lymphocytes for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma (CART CD30)WithdrawnNCT01316146Phase 1
- Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent PanitumumabWithdrawnNCT01312493Phase 2
- Study of the P16 Gene as a Predictor of Myelosuppression in Breast Cancer PatientsCompletedNCT01305954
- Study of BKM120 or BYL719 and Capecitabine in Patients With Metastatic Breast CancerCompletedNCT01300962Phase 1
- Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell LymphomasWithdrawnNCT01263418Phase 2
- Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue SarcomaTerminatedNCT01204450Phase 1
- Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian CancerTerminatedNCT01175967
- PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute LeukemiasCompletedNCT01169012Phase 1
- Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination ChemotherapyCompletedNCT01164215Phase 1
- Mammography Reminders for Encouraging Women to Undergo Regular Mammography Screenings for Breast CancerCompletedNCT01148875
- Biomarkers in Blood Samples From Older Breast Cancer SurvivorsCompletedNCT01138345
- Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving ChemotherapyCompletedNCT01132833
- Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryCompletedNCT01011010Phase 1
- Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With ChemotherapyWithdrawnNCT00998101Phase 2
- Trastuzumab and External Beam Radiation Therapy in Treating Women With Stage III or Stage IV Breast CancerCompletedNCT00943410Phase 2
- Digital Breast Tomosynthesis Preference StudyCompletedNCT00776126
- Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and CirrhosisTerminatedNCT00767468Phase 1
- Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple MyelomaTerminatedNCT00744354Phase 1
- Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast CancerCompletedNCT00719173Phase 1
- Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to TreatmentCompletedNCT00610948Phase 1
- Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT00577694Phase 1
- Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid TumorsCompletedNCT00573690Phase 1
- Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal CancerCompletedNCT00520091Phase 2
- Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid TumorsCompletedNCT00520000Phase 1
← UNC Lineberger Comprehensive Cancer Center overview and focus areas